Dermatology-related epidemiologic and clinical concerns of men who have sex with men, women who have sex with women, and transgender individuals

Archives of Dermatology

Volumn 141, Issue 10, 2005, Pages 1303-1310

  Katz, Kenneth A ^a   Furnish, Timothy J ^b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c CROZER CHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL PRACTICE; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEDICAL SPECIALIST; MINORITY GROUP; NOMENCLATURE; PATIENT CARE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE; SKIN DISEASE; SKIN INFECTION; TRANSSEXUALISM;

DISEASE OUTBREAKS; FEMALE; HOMOSEXUALITY, FEMALE; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; SKIN DISEASES; TERMINOLOGY; TRANSSEXUALISM;

EID: 27144519222     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.141.10.1303     Document Type: Review

References (80)

1. Centers for Disease Control and Prevention. Pneumocystis pneumonia-Los Angeles. MMWR Morb Mortal Wkly Rep. 1981;30:250-252.
2. Centers for Disease Control and Prevention. Kaposi's sarcoma and pneumocystis pneumonia among homosexual men-New York City and California. MMWR Morb Mortal Wkly Rep. 1981;30:305-308.
3. Friedman-Kien AE, Cockerell CJ. Color Atlas of AIDS . Philadelphia, Pa: WB Saunders Co; 1996.
4. Wu JJ, Huang DB, Pang KR, Tyring SK. Selected sexually transmitted diseases and their relationship to HIV. Clin Dermatol. 2004;22:499-508.
5. Burnouf M, Buffet M, Schwarzinger M, et al. Evaluation of Coleman's lipostructure for treatment of facial lipoatrophy in patients with human immunodeficiency virus and parameters associated with efficiency of this technique. Arch Dermatol. 2005;141:1220-1224.
6. Tuller D. HIV patients try to remedy gaunt appearance. New York Times. May 21, 2002;§F:6.
7. Collins E, Wagner C, Walmsley S. Psychosocial impact of the lipodystrophy syndrome in HIV infection. AIDS Read. 2000;10:546-551.
8. Burgess CM, Quiroga RM. Assessment of the safety and efficacy of poly-Llactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol. 2005;52:233-239.
9. Comite SL, Liu JF, Balasubramanian S, Christian MA. Treatment of HIV-associated facial lipoatrophy with Radiance FN (Radiesse). Dermatol Online J. 2004;10:2.
10. Lafaurie M, Dolivo M, Porcher R, Rudant J, Madelaine I, Molina JM. Treatment of facial lipoatrophy with intradermal injections of polylactic acid in HIV-infected patients. J Acquir Immune Defic Syndr. 2005;38:393-398.
11. Orentreich D, Leone AS. A case of HIV-associated facial lipoatrophy treated with 1000-cs liquid injectable silicone. Dermatol Surg. 2004;30:548-551.
12. Centers for Disease Control and Prevention. HIV/STD risks in young men who have sex with men who do not disclose their sexual orientation-six U.S. cities, 1994-2000. MMWR Morb Mortal Wkly Rep. 2003;52:81-85.
13. Goodrum AJ. Gender identity 101: a transgender primer. Available at: http://www.sagatucson.org/resources/infotop.htm. Accessed March 28, 2005.
14. Creighton SM, Minto CL, Liao LM, Alderson J, Simmonds M. Meeting between experts: evaluation of the first UK forum for lay and professional experts in intersex. Patient Educ Couns. 2004;54:153-157.
15. Brown J, Warne G. Practical management of the intersex infant. J Pediatr Endocrinol Metab. 2005;18:3-23.
16. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. 2002. Available at: http://www.cdc.gov/hiv/stats/hasrlink.htm. Accessed August 5, 2005.
17. Catania JA, Osmond D, Stall RD, et al. The continuing HIV epidemic among men who have sex with men. Am J Public Health. 2001;91:907-914.
18. Centers for Disease Control and Prevention. Increases in HIV diagnoses-29 states, 1999-2002. MMWR Morb Mortal Wkly Rep. 2003;52:1145-1148.
19. Centers for Disease Control and Prevention. HIV incidence among young men who have sex with men-seven U.S. cities, 1994-2000. MMWR Morb Mortal Wkly Rep. 2001;50:440-444.
20. Centers for Disease Control and Prevention. HIV/AIDS among racial/ethnic minority men who have sex with men-United States, 1989-1998. MMWR Morb Mortal Wkly Rep. 2000;49:4-11.
21. Spira R, Mignard M, Doutre M, et al. Prevalence of cutaneous disorders in a population of HIV-infected patients: southwestern France, 1996. Arch Dermatol. 1998;134:1208-1212.
22. Johnson R. Cutaneous manifestations of human immunodeficiency virus disease. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, eds. Fitzpatrick's Dermatology in General Medicine. New York, NY: McGraw-Hill Co;2003:2138-2150.
23. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet. 1990;335:123-128.
24. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med. 1998;338:948-954.
25. Rietmeijer CA, Patnaik JL, Judson FN. Increases in gonorrhea and sexual risk behaviors among men who have sex with men: a 12-year trend analysis at the Denver Metro Health Clinic. Sex Transm Dis. 2003;30:562-567.
26. Katz MH, Schwarcz SK, Kellogg TA, et al. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. Am J Public Health. 2002;92:388-394.
27. Centers for Disease Control and Prevention. Resurgent bacterial sexually transmitted disease among men who have sex with men-King County, Washington, 1997-1999. MMWR Morb Mortal Wkly Rep. 1999;48:773-777.
28. Fox KK, del Rio C, Holmes KK, et al. Gonorrhea in the HIV era: a reversal in trends among men who have sex with men. Am J Public Health. 2001;91:959-964.
29. Centers for Disease Control and Prevention. Increases in fluoroquinoloneresistant Neisseria gonorrhoeae among men who have sex with men-United States, 2003, and revised recommendations for gonorrhea treatment, 2004.MMWR Morb Mortal Wkly Rep. 2004;53:335-338.
30. Centers for Disease Control and Prevention. Primary and secondary syphilis among men who have sex with men-New York City, 2001. MMWR Morb Mortal Wkly Rep. 2002;51:853-856.
31. Centers for Disease Control and Prevention. Outbreak of syphilis among men who have sex with men-Southern California, 2000. MMWR Morb Mortal Wkly Rep. 2001;50:117-120.
32. Giuliani M, Palamara G, Latini A, Maini A, Di Carlo A. Evidence of an outbreak of syphilis among men who have sex with men in Rome. Arch Dermatol. 2005;141:100-101.
33. Centers for Disease Control and Prevention. Primary and secondary syphilis-United States, 2002. MMWR Morb Mortal Wkly Rep. 2002;52:1117-1120.
34. Centers for Disease Control and Prevention. Trends in primary and secondary syphilis and HIV infections in men who have sex with men-San Francisco and Los Angeles, California, 1998-2002. MMWR Morb Mortal Wkly Rep. 2004;53:575-578.
35. Centers for Disease Control and Prevention. Azithromycin treatment failures in syphilis infections-San Francisco, California, 2002-2003. MMWR Morb Mortal Wkly Rep. 2004;53:197-198.
36. Renzi C, Douglas JM, Foster M, et al. Herpes simplex virus type 2 infection as a risk factor for human immunodeficiency virus acquisition in men who have sex with men. J Infect Dis. 2003;187:19-25.
37. Tabet SR, Krone MR, Paradise MA, Corey L, Stamm WE, Celum CL. Incidence of HIV and sexually transmitted diseases (STD) in a cohort of HIV-negative men who have sex with men (MSM). AIDS. 1998;12:2041-2048.
38. Centers for Disease Control and Prevention. Lymphogranuloma venereum among men who have sex with men-Netherlands, 2003-2004. MMWR Morb Mortal Wkly Rep. 2004;53:985-988.
39. Meyer T, Arndt R, von Krosigk A, Plettenberg A. Repeated detection of lymphogranuloma venereum caused by Chlamydia trachomatis L2 in homosexual men in Hamburg [letter]. Sex Transm Infect. 2005;81:91-92.
40. Nieuwenhuis RF, Ossewaarde JM, Gotz HM, et al. Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar l2 proctitis in The Netherlands among men who have sex with men. Clin Infect Dis. 2004;39:996-1003.
41. Friedlander MA, Stier E, Lin O. Anorectal cytology as a screening tool for anal squamous lesions: cytologic, anoscopic, and histologic correlation. Cancer. 2004;102:19-26.
42. Piketty C, Darragh TM, Heard I, et al. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis. 2004;31:96-99.
43. Sobhani I, Walker F, Roudot-Thoraval F, et al. Anal carcinoma: incidence and effect of cumulative infections. AIDS. 2004;18:1561-1569.
44. Friedman HB, Saah AJ, Sherman ME, Busseniers AE, Blackwelder WC, Kaslow RA. Human papillomavirus, anal squamous intraepithelial lesions, and human immunodeficiency virus in a cohort of gay men. J Infect Dis. 1998;178:45-52.
45. Kiviat NB, Critchlow CW, Holmes KK, et al. Association of anal dysplasia and human papillomavirus with immunosuppression and HIV infection among homosexual men. AIDS. 1993;7:43-49.
46. Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in HIV-positive and HIV-negative homosexual men. J Infect Dis. 1998;177:361-367.
47. Kreuter A, Brockmeyer N, Hochdorfer B, et al. Clinical spectrum and virologic characteristics of anal intraepithelial neoplasia in HIV infection. J Am Acad Dermatol. 2005;52:603-608.
48. de Sanjose S, Palefsky J. Cervical and anal HPV infections in HIV positive women and men. Virus Res. 2002;89:201-211.
49. Centers for Disease Control and Prevention. MSM Information Center Web page. Available at: http://www.cdc.gov/ncidod/diseases/hepatitis/msm/education. htm. Accessed September 26, 2004.
50. Centers for Disease Control and Prevention. Hepatitis A vaccination of men who have sex with men-Atlanta, Georgia, 1996-7. MMWR Morb Mortal Wkly Rep. 1998;34:708-711.
51. Centers for Disease Control and Prevention. Incidence of acute hepatitis B-United States, 1990-2002. MMWR Morb Mortal Wkly Rep. 2004;52:1252-1254.
52. MacKellar DA, Valleroy LA, Secura GM, et al. Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with men. Am J Public Health. 2001;91:965-971.
53. Centers for Disease Control and Prevention. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections-Los Angeles County, California, 2002-3. MMWR Morb Mortal Wkly Rep. 2003;52:88.
54. Iyer S, Jones DH. Community-acquired methicillin-resistant Staphylococcus aureus skin infection: a retrospective analysis of clinical presentation and treatment of a local outbreak. J Am Acad Dermatol. 2004;50:854-858.
55. O'Neill JF, Shalit P. Health care of the gay male patient. Prim Care. 1992;19:191-201.
56. Bolding G, Sherr L, Elford J. Use of anabolic steroids and associated health risks among gay men attending London gyms. Addiction. 2002;97:195-203.
57. Bailey JV, Farquhar C, Owen C, Mangtani P. Sexually transmitted infections in women who have sex with women. Sex Transm Infect. 2004;80:244-246.
58. Hughes D. Disclosure of sexual preferences and lesbian, gay, and bisexual practitioners. BMJ. 2004;328:1211-1212.
59. Marrazzo JM, Koutsky LA, Kiviat NB, Kuypers JM, Stine K. Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women. Am J Public Health. 2001;91:947-952.
60. Marrazzo JM, Stine K, Wald A. Prevalence and risk factors for infection with herpes simplex virus type-1 and -2 among lesbians. Sex Transm Dis. 2003;30:890-895.
61. Scheer S, Peterson I, Page-Shafer K, et al. Sexual and drug use behavior among women who have sex with both women and men: results of a population-based survey. Am J Public Health. 2002;92:1110-1112.
62. Kellogg TA, Clements-Nolle K, Dilley J, Katz MH, McFarland W. Incidence of human immunodeficiency virus among male-to-female transgendered persons in San Francisco. J Acquir Immune Defic Syndr. 2001;28:380-384.
63. Simon PA, Reback CJ, Bemis CC. HIV prevalence and incidence among maleto-female transsexuals receiving HIV prevention services in Los Angeles County. AIDS. 2000;14:2953-2955.
64. Van Kesteren P, Asscheman H, Megens J, Gooren L. Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol (Oxf). 1997;47:337-342.
65. Giltay EJ, Gooren LJG. Effects of sex steroid deprivation/administration on hair growth and skin sebum production in transsexual males and females. J Clin Endocrinol Metab. 2000;85:2913-2921.
66. Schroeter CA, Groenewegen JS, Reineke T, Neumann HAM. Ninety percent permanent hair reduction in transsexual patients. Ann Plast Surg. 2003;51:243-247.
67. Fox LP, Geyer AS, Husain S, Della-Latta P, Grossman ME. Mycobacterium abscessus cellulitis and multifocal abscesses of the breasts in a transsexual from illicit intramammary injections of silicone. J Am Acad Dermatol. 2004;50:450-454.
68. Harder Y, Erni D, Banic A. Squamous cell carcinoma of the penile skin in a neovagina 20 years after male-to-female reassignment. Br J Plast Surg. 2002;55:449-451.
69. Farina LA, Palacio V, Salles M, Fernandez-Villanueva D, Vidal B, Menendez P. Scrotal granuloma caused by oil migrating from the hip in 2 transsexual males (scrotal sclerosing lipogranuloma) [in Spanish]. Arch Esp Urol. 1997;50:51-53.
70. Gaber Y. Secondary lymphoedema of the lower leg as an unusual side-effect of a liquid silicone injection in the hips and buttocks. Dermatology. 2004;208:342-344.
71. Feldman J, Bockting W. Transgender health. Minn Med. 2003;86:25-32.
72. American Medical Association. H-160.991 health care needs of the homosexual population. Available at: http://www.ama-assn.org/apps/pf_new/ pf_online?f _n=browse&doc=policyfiles/HnE/H-160.991.HTM. Accessed September 28, 2004.
73. Boards of directors take action on key dermatology, Academy issues. Dermatology World. June 2005:16.
74. American Academy of Dermatology. Bylaws. Available at: http://www.aad.org /aad/AbouttheAAD/bylaws.htm. Accessed June 14, 2005.
75. Dean L, Meyer IH, Robinson K, et al. Lesbian, gay, bisexual, and transgender health: findings and concerns. JGLMA. 2000;4:101-151.
76. Schatz B, O'Hanlan KA. Anti-Gay Discrimination in Medicine: Results of a National Survey of Lesbian, Gay and Bisexual Physicians. San Francisco, Calif: Gay and Lesbian Medical Association; 1994.
77. Mathieson C. Lesbian and bisexual health care: straight talk about experiences with physicians. Can Fam Physician. 1998;44:1634-1640.
78. Gay and Lesbian Medical Association. Creating a Safe Clinical Environment for LGBTI Patients. San Francisco, Calif: Gay and Lesbian Medical Association [undated].
79. Bonvicini KA, Perlin MJ. The same but different: clinician-patient communication with gay and lesbian patients. Patient Educ Couns. 2003;51:115-122.
80. Rose L. Homophobia among doctors. BMJ. 1994;308:586-587.